The Effect of Intra-articular Bilateral Knee Injections of Zilretta on Performance Measures in Adults With Knee OA
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03895840 |
Recruitment Status :
Recruiting
First Posted : March 29, 2019
Last Update Posted : September 23, 2020
|
Sponsor:
University of Kansas Medical Center
Information provided by (Responsible Party):
University of Kansas Medical Center
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Recruiting |
---|---|
Estimated Primary Completion Date : | March 10, 2021 |
Estimated Study Completion Date : | March 10, 2021 |
Publications:
P. Conaghan, V. Strand, D. Hunter. An intra-articular, extended release formulation of triamcinolone (FX006) affords clinically relevant improvements in pain and function of knee osteoarthritis: post-hoc pooled analyses of 3 randomized controlled trials. Osteoarthritis and Cartilage April 2017,Volume 25, Supplement 1, Pages S432-S433